CoChat

Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes

Open access
Zhao, Lihui, Teng, Miaomiao, Zhao, Xiaoli, Li, Yunxia, Sun, Jiaqi, Zhao, Wentian, Ruan, Yuefei, Leung, Kenneth M.Y., Wu, Fengchang · 2023 · Environment International
Cited by 218

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Legacy per- and polyfluoroalkyl substances (PFASs) have elicited much concern because of their ubiquitous distribution in the environment and the potential hazards they pose to wildlife and human health. Although an increasing number of effective PFAS alternatives are available in the market, these alternatives bring new challenges. This paper comprehensively reviews how PFASs bind to transport proteins (e.g., serum albumin, liver fatty acid transport proteins and organic acid transporters), nuclear receptors (e.g., peroxisome proliferator activated receptors, thyroid hormone receptors and reproductive hormone receptors) and membranes (e.g., cell membrane and mitochondrial membrane). Briefly, the hydrophobic fluorinated carbon chains of PFASs occupy the binding cavities of the target proteins, and the acid groups of PFASs form hydrogen bonds with amino acid residues. Various structural features of PFAS alternatives such as chlorine atom substitution, oxygen atom insertion and a branched structure, introduce variations in their chain length and hydrophobicity, which potentially change the affinity of PFAS alternatives for endogenous proteins. The toxic effects and mechanisms of action of legacy PFASs can be demonstrated and compared with their alternatives using binding models. In future studies, in vitro experiments and in silico quantitative structure-activity relationship modeling should be better integrated to allow more reliable toxicity predictions for both legacy and alternative PFASs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.envint.2023.107951

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 108

  1. Abbott, 2007, Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha, Toxicol. Sci., 98, 571, 10.1093/toxsci/kfm110 · DOI · Paper page
  2. Alves, 2017, A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity, J. R. Soc. Interface, 14, 20170408, 10.1098/rsif.2017.0408 · DOI
  3. Atshaves, 2010, Liver fatty acid-binding protein and obesity, J. Nutr. Biochem., 21, 1015, 10.1016/j.jnutbio.2010.01.005 · DOI · Paper page
  4. Banjabi, 2020, Serum concentrations of perfluoroalkyl substances and their association with osteoporosis in a population in Jeddah, Saudi Arabia. Environmental Research, 187
  5. Becanova, 2016, Screening for perfluoroalkyl acids in consumer products, building materials and wastes, Chemosphere, 164, 322, 10.1016/j.chemosphere.2016.08.112 · DOI · Paper page
  6. Benninghoff, 2011, Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro, Toxicol. Sci., 120, 42, 10.1093/toxsci/kfq379 · DOI · Paper page
  7. Berger, 2002, Physiological and therapeutic roles of peroxisome proliferator-activated receptors, Diabetes Technol. Ther., 4, 163, 10.1089/15209150260007381 · DOI · Paper page
  8. Bjork, 2011, Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes, Toxicology, 288, 8, 10.1016/j.tox.2011.06.012 · DOI · Paper page
  9. Camdzic, 2022, Cellular Interactions and Fatty Acid Transporter CD36-Mediated Uptake of Per- and Polyfluorinated Alkyl Substances (PFAS), Chem. Res. Toxicol., 694, 10.1021/acs.chemrestox.2c00078 · DOI
  10. Cao, 2019, Screening of Potential PFOS Alternatives To Decrease Liver Bioaccumulation: Experimental and Computational Approaches, Environ. Sci. Tech., 53, 2811, 10.1021/acs.est.8b05564 · DOI · Paper page
  11. Cao, 2022, Effect of Enterohepatic Circulation on the Accumulation of Per- and Polyfluoroalkyl Substances: Evidence from Experimental and Computational Studies, Environ. Sci. Tech., 56, 3214, 10.1021/acs.est.1c07176 · DOI · Paper page
  12. Cha, 2000, Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta, J. Biol. Chem., 275, 4507, 10.1074/jbc.275.6.4507 · DOI · Paper page
  13. Chang, 2008, Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS), Toxicology, 243, 330, 10.1016/j.tox.2007.10.014 · DOI · Paper page
  14. Chávez-Galán, 2009, Cell Death Mechanisms Induced by Cytotoxic Lymphocytes, Cell. Mol. Immunol., 6, 15, 10.1038/cmi.2009.3 · DOI · Paper page
  15. Chen, 2001, Role of mitochondrial dysfunction in S-(1,2-dichlorovinyl)-l-cysteine-induced apoptosis, Toxicol. Appl. Pharmacol., 170, 172, 10.1006/taap.2000.9107 · DOI
  16. Cheng, 2017, A permeability-limited physiologically based pharmacokinetic (PBPK) model for perfluorooctanoic acid (PFOA) in male rats, Environ. Sci. Tech., 51, 9930, 10.1021/acs.est.7b02602 · DOI · Paper page
  17. Cheng, 2019, Using Machine Learning to Classify Bioactivity for 3486 Per- and Polyfluoroalkyl Substances (PFASs) from the OECD List, Environ. Sci. Tech., 53, 13970, 10.1021/acs.est.9b04833 · DOI · Paper page
  18. Choi, 2014, Revisiting PPARgamma as a target for the treatment of metabolic disorders, BMB Rep., 47, 599, 10.5483/BMBRep.2014.47.11.174 · DOI
  19. Coperchini, 2020, Thyroid disrupting effects of old and new generation PFAS, Front Endocrinol (Lausanne), 11
  20. Cui, 2020, Exposure to per- and polyfluoroalkyl substances (PFASs) in serum versus semen and their association with male reproductive hormones, Environ. Pollut., 266, 10.1016/j.envpol.2020.115330 · DOI
  21. Daems, 2021, Native mass spectrometry for the design and selection of protein bioreceptors for perfluorinated compounds, Analyst, 146, 2065, 10.1039/D0AN02005B · DOI
  22. De Toni, 2020, Increased cardiovascular risk associated with chemical sensitivity to perfluoro–octanoic acid: role of impaired platelet aggregation, Int. J. Mol. Sci., 21, 399, 10.3390/ijms21020399 · DOI · Paper page
  23. Delva-Wiley, 2021, Computational Analysis of the Binding Mechanism of GenX and HSA, ACS Omega, 6, 29166, 10.1021/acsomega.1c04592 · DOI
  24. Deng, 2018, Multiple approaches to assess the effects of F-53B, a Chinese PFOS alternative, on thyroid endocrine disruption at environmentally relevant concentrations, Sci. Total Environ., 624, 215, 10.1016/j.scitotenv.2017.12.101 · DOI
  25. Duan, 2021, Perfluorooctane sulfonate continual exposure impairs glucose-stimulated insulin secretion via SIRT1-induced upregulation of UCP2 expression, Environ. Pollut., 278, 10.1016/j.envpol.2021.116840 · DOI
  26. Dunder, 2022, Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years, Environ. Res., 211, 10.1016/j.envres.2022.112903 · DOI · Paper page
  27. Endo, 2022, Applicability Domain of Polyparameter Linear Free Energy Relationship Models Evaluated by Leverage and Prediction Interval Calculation, Environ. Sci. Tech., 56, 5572, 10.1021/acs.est.2c00865 · DOI · Paper page
  28. Fedorenko, 2021, Dominant entropic binding of perfluoroalkyl substances (PFASs) to albumin protein revealed by (19)F NMR, Chemosphere, 263, 10.1016/j.chemosphere.2020.128083 · DOI · Paper page
  29. Forsthuber, 2020, Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma, Environ. Int., 137, 10.1016/j.envint.2019.105324 · DOI · Paper page
  30. Furuhashi, 2008, Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets, Nat. Rev. Drug Discov., 7, 489, 10.1038/nrd2589 · DOI · Paper page
  31. Gallo, 2012, Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure, Environ. Health Perspect., 120, 655, 10.1289/ehp.1104436 · DOI · Paper page
  32. Gao, 2013, Assessment of estrogenic activity of perfluoroalkyl acids based on ligand-induced conformation state of human estrogen receptor, Environ. Sci. Tech., 47, 634, 10.1021/es304030x · DOI · Paper page
  33. Gao, 2015, Differential accumulation and elimination behavior of perfluoroalkyl Acid isomers in occupational workers in a manufactory in China, Environ. Sci. Tech., 49, 6953, 10.1021/acs.est.5b00778 · DOI · Paper page
  34. Golius, 2016, Experimental and computational study of membrane affinity for selected energetic compounds, Chemosphere, 148, 322, 10.1016/j.chemosphere.2016.01.010 · DOI
  35. Gordon, 2011, Toxicological evaluation of ammonium 4,8-dioxa-3H-perfluorononanoate, a new emulsifier to replace ammonium perfluorooctanoate in fluoropolymer manufacturing, Regul. Toxicol. Pharm., 59, 64, 10.1016/j.yrtph.2010.09.008 · DOI
  36. Han, 2003, Binding of Perfluorooctanoic Acid to Rat and Human Plasma Proteins, Chem. Res. Toxicol., 16, 775, 10.1021/tx034005w · DOI · Paper page
  37. Henley, 2009, The short-chain fatty acid methoxyacetic acid disrupts endogenous estrogen receptor-alpha-mediated signaling, Environ. Health Perspect., 117, 1702, 10.1289/ehp.0900800 · DOI
  38. Hernandez, 2022, Proteins as adsorbents for PFAS removal from water, Environ. Sci. Water Res. Technol., 8, 1188, 10.1039/D1EW00501D · DOI
  39. Houck, 2021, Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure, Toxicology, 457, 10.1016/j.tox.2021.152789 · DOI · Paper page
  40. Hu, 2003, Alterations in cell membrane properties caused by perfluorinated compounds, Comp. Biochem. Physiol. C: Toxicol. Pharmacol., 135, 77
  41. Hu, 2002, Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo, Toxicol. Sci., 68, 429, 10.1093/toxsci/68.2.429 · DOI · Paper page
  42. Huang, 2021, Developmental toxicity of the novel PFOS alternative OBS in developing zebrafish: An emphasis on cilia disruption, J. Hazard. Mater., 409, 10.1016/j.jhazmat.2020.124491 · DOI
  43. Jane, 2022, Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOA, Environ. Res., 212
  44. Jones, 2003, Binding of perfluorinated fatty acids to serum proteins, Environ. Toxicol. Chem., 22, 2639, 10.1897/02-553 · DOI · Paper page
  45. Kar, 2017, Endocrine-disrupting activity of per- and polyfluoroalkyl substances: Exploring combined approaches of ligand and structure based modeling, Chemosphere, 184, 514, 10.1016/j.chemosphere.2017.06.024 · DOI
  46. Khazaee, 2021, Perfluoroalkyl acid binding with peroxisome proliferator-activated receptors α, γ, and δ, and fatty acid binding proteins by equilibrium dialysis with a comparison of methods, Toxics, 9, 45, 10.3390/toxics9030045 · DOI · Paper page
  47. Kjeldsen, 2013, Perfluorinated compounds affect the function of sex hormone receptors, Environ. Sci. Pollut. Res., 20, 8031, 10.1007/s11356-013-1753-3 · DOI · Paper page
  48. Kleszczynski, 2009, Mechanism of cytotoxic action of perfluorinated acids. I. alteration in plasma membrane potential and intracellular pH level, Toxicol. Appl. Pharmacol., 234, 300, 10.1016/j.taap.2008.10.008 · DOI
  49. Kleszczynski, 2011, Mechanism of cytotoxic action of perfluorinated acids. III. Disturbance in Ca(2)+ homeostasis, Toxicol. Appl. Pharmacol., 251, 163, 10.1016/j.taap.2011.01.002 · DOI
  50. Kleszczynski, 2009, Mechanism of cytotoxic action of perfluorinated acids II. Disruption of mitochondrial bioenergetics, Toxicol. Appl. Pharmacol., 235, 182, 10.1016/j.taap.2008.11.021 · DOI
  51. Koupenova, 2018, Biology of platelet purinergic receptors and implications for platelet heterogeneity, Front Pharmacology, 9, 37, 10.3389/fphar.2018.00037 · DOI
  52. Kummu, 2015, Organic anion transporter 4 (OAT 4) modifies placental transfer of perfluorinated alkyl acids PFOS and PFOA in human placental ex vivo perfusion system, Placenta, 36, 1185, 10.1016/j.placenta.2015.07.119 · DOI
  53. Li, 2020, Evaluation of the Estrogenic/Antiestrogenic Activities of Perfluoroalkyl Substances and Their Interactions with the Human Estrogen Receptor by Combining In Vitro Assays and In Silico Modeling, Environ. Sci. Tech., 54, 14514, 10.1021/acs.est.0c03468 · DOI
  54. Li, 2018, Perfluorooctane sulfonate impairs rat Leydig cell development during puberty, Chemosphere, 190, 43, 10.1016/j.chemosphere.2017.09.116 · DOI
  55. Li, 2019, Investigation of binding and activity of perfluoroalkyl substances to the human peroxisome proliferator-activated receptor beta/delta, Environ. Sci. Processes Impacts, 21, 1908, 10.1039/C9EM00218A · DOI · Paper page
  56. Li, 2019, Adipogenic activity of oligomeric hexafluoropropylene oxide (perfluorooctanoic acid alternative) through peroxisome proliferator-activated receptor γ pathway, Environ. Sci. Tech., 53, 3287, 10.1021/acs.est.8b06978 · DOI · Paper page
  57. Liu, 2018, Bioaccumulation and effects of novel chlorinated polyfluorinated ether sulfonate in freshwater alga Scenedesmus obliquus, Environ. Pollut., 233, 8, 10.1016/j.envpol.2017.10.039 · DOI
  58. Liu, 2021, Prenatal and postnatal transfer of perfluoroalkyl substances from mothers to their offspring, Crit. Rev. Environ. Sci. Technol., 1
  59. Liu, 2021, Associations between six common per- and polyfluoroalkyl substances and estrogens in neonates of China, J. Hazard. Mater., 407, 10.1016/j.jhazmat.2020.124378 · DOI · Paper page
  60. Lu, 2021, The occurrence of PFAS in human placenta and their binding abilities to human serum albumin and organic anion transporter 4, Environ. Pollut., 273, 10.1016/j.envpol.2021.116460 · DOI · Paper page
  61. Luo, 2012, Structural evidence of perfluorooctane sulfonate transport by human serum albumin, Chem. Res. Toxicol., 25, 990, 10.1021/tx300112p · DOI · Paper page
  62. Lv, 2021, The molecular-level understanding of the uptake of PFOS and its alternatives (6:2 Cl-PFESA and OBS) into phospholipid bilayers, J. Hazard. Mater., 417, 10.1016/j.jhazmat.2021.125991 · DOI
  63. Mann, 2022, Engineering human liver fatty acid binding protein for detection of poly- and perfluoroalkyl substances, Biotechnol Bioeng, 119, 513, 10.1002/bit.27981 · DOI
  64. Martin, 2007, Toxicogenomic Study of Triazole Fungicides and Perfluoroalkyl Acids in Rat Livers Predicts Toxicity and Categorizes Chemicals Based on Mechanisms of Toxicity, Toxicol. Sci., 97, 595, 10.1093/toxsci/kfm065 · DOI · Paper page
  65. Maso, 2021, Unveiling the binding mode of perfluorooctanoic acid to human serum albumin, Protein Sci., 30, 830, 10.1002/pro.4036 · DOI
  66. Moller, 1982, Renal organic anion transport system: pharmacological physiological, and biochemical aspects, Pharmacol. Rev., 34, 315, 10.1016/S0031-6997(25)00055-9 · doi:10.1016/s0031-6997(25)00055-9
  67. Mortensen, 2020, Homology modeling to screen for potential binding of contaminants to thyroid hormone receptor and transthyretin in glaucous gull (Larus hyperboreus) and herring gull (Larus argentatus), Comput. Toxicol., 13, 10.1016/j.comtox.2020.100120 · DOI
  68. Nakagawa, 2008, Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid, Basic Clin. Paharmacol. Toxicol., 103, 1, 10.1111/j.1742-7843.2007.00155.x · DOI · Paper page
  69. Ng, 2015, Exploring the Use of Molecular Docking to Identify Bioaccumulative Perfluorinated Alkyl Acids (PFAAs), Environ. Sci. Tech., 49, 12306, 10.1021/acs.est.5b03000 · DOI · Paper page
  70. Nielsen, 2022, Predicting the effects of per-and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro, Toxicology, 153024
  71. Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-g, Nature, 395, 137, 10.1038/25931 · DOI · Paper page
  72. Olsen, 2017, Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000–2015, Environ. Res., 157, 87, 10.1016/j.envres.2017.05.013 · DOI · Paper page
  73. Palioura, 2022, PPARβ/δ at the crossroads of energy metabolism, mitochondrial quality control and redox balance, Journal of Biological Research - Thessaloniki, 29
  74. Qu, 2018, Perfluorinated compounds binding to estrogen receptor of different species: a molecular dynamic modeling, J. Mol. Model., 25, 1, 10.1007/s00894-018-3878-2 · DOI
  75. Ren, 2015, Structure-activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor, Arch. Toxicol., 89, 233, 10.1007/s00204-014-1258-y · DOI · Paper page
  76. Ren, 2016, Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications, Toxicology, 366–367, 32, 10.1016/j.tox.2016.08.011 · DOI · Paper page
  77. Richieri, 2000, Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions, Biochemistry, 39, 7197, 10.1021/bi000314z · DOI · Paper page
  78. Rodowa, 2020, Field Sampling Materials Unlikely Source of Contamination for Perfluoroalkyl and Polyfluoroalkyl Substances in Field Samples, Environ. Sci. Technol. Lett., 7, 156, 10.1021/acs.estlett.0c00036 · DOI · Paper page
  79. Schroeder, 2001, Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells, Mol. Cell. Biochem., 219, 127, 10.1023/A:1010851130136 · DOI
  80. Schultza, 2003, Definitely quantitative structure-activity relationship (QSAR) models together with molecular simulation methods were permitted to predict health adverse impacts, J. Mol. Struct. (Thoechem), 622, 1
  81. Shen, 2020, Cholesterol-like condensing effect of perfluoroalkyl substances on a phospholipid bilayer, J. Phys. Chem. B, 124, 5415, 10.1021/acs.jpcb.0c00980 · DOI
  82. Sheng, 2016, Interaction of perfluoroalkyl acids with human liver fatty acid-binding protein, Arch Toxicol, 90, 217, 10.1007/s00204-014-1391-7 · DOI · Paper page
  83. Sheng, 2020, Interactions of perfluorooctanesulfonate and 6: 2 chlorinated polyfluorinated ether sulfonate with human serum albumin: a comparative study, Chem. Res. Toxicol., 33, 1478, 10.1021/acs.chemrestox.0c00075 · DOI
  84. Shi, 2012, Tissue distribution of perfluorinated compounds in farmed freshwater fish and human exposure by consumption, Environ. Toxicol. Chem., 31, 717, 10.1002/etc.1758 · DOI · Paper page
  85. Shoeib, 2016, Poly- and perfluoroalkyl substances (PFASs) in indoor dust and food packaging materials in Egypt: Trends in developed and developing countries, Chemosphere, 144, 1573, 10.1016/j.chemosphere.2015.08.066 · DOI
  86. Soderstrom, 2022, Agonistic and potentiating effects of perfluoroalkyl substances (PFAS) on the Atlantic cod (Gadus morhua) peroxisome proliferator-activated receptors (Ppars), Environ. Int., 163, 10.1016/j.envint.2022.107203 · DOI
  87. Steenland, 2021, PFAS and cancer, a scoping review of the epidemiologic evidence, Environ. Res., 194, 10.1016/j.envres.2020.110690 · DOI · Paper page
  88. Suresh Babu, 2022, Experimental insights into anodic oxidation of hexafluoropropylene oxide dimer acid (GenX) on boron-doped diamond anodes, Chemosphere, 288, 10.1016/j.chemosphere.2021.132417 · DOI
  89. Tu, 2019, Bioconcentration and metabolic effects of emerging PFOS alternatives in developing zebrafish, Environ. Sci. Tech., 53, 13427, 10.1021/acs.est.9b03820 · DOI
  90. Ugele, 2003, Characterization and identification of steroid sulfatetransporters of human placenta, American Journal of Physiology-Endocrinology and Metabolism, 284, E390, 10.1152/ajpendo.00257.2002 · DOI · Paper page
  91. Wang, 2019, PFOS, PFOA, estrogen homeostasis, and birth size in Chinese infants, Chemosphere, 221, 349, 10.1016/j.chemosphere.2019.01.061 · DOI · Paper page
  92. Wang, 2017, Serum metabolome biomarkers associate low-level environmental perfluorinated compound exposure with oxidative /nitrosative stress in humans, Environ. Pollut., 229, 168, 10.1016/j.envpol.2017.04.086 · DOI
  93. Weaver, 2010, Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths, Toxicol. Sci., 113, 305, 10.1093/toxsci/kfp275 · DOI · Paper page
  94. Weiss, 2009, Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin, Toxicol. Sci., 109, 206, 10.1093/toxsci/kfp055 · DOI · Paper page
  95. Wen, 2015, Unliganded thyroid hormone receptor alpha controls developmental timing in Xenopus tropicalis, Endocrinology, 156, 721, 10.1210/en.2014-1439 · DOI
  96. Wolf, 2008, Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths, Toxicol. Sci., 106, 162, 10.1093/toxsci/kfn166 · DOI · Paper page
  97. Wu, 2017, Analysis of perfluorinated compounds in human serum from the general population in Shanghai by liquid chromatography-tandem mass spectrometry (LC-MS/MS), Chemosphere, 168, 100, 10.1016/j.chemosphere.2016.09.161 · DOI
  98. Wu, 2022, Global performance and trends of research on per- and polyfluoroalkyl substances (PFASs) between 2001 and 2018 using bibliometric analysis, Chemosphere, 295, 10.1016/j.chemosphere.2022.133853 · DOI
  99. Xiao, 2017, An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT), Clin. Res. Hepatol. Gastroenterol., 41, 509, 10.1016/j.clinre.2017.02.001 · DOI
  100. Xin, 2019, Comparative in vitro and in vivo evaluation of the estrogenic effect of hexafluoropropylene oxide homologues, Environ. Sci. Tech., 53, 8371, 10.1021/acs.est.9b01579 · DOI · Paper page
  101. Yang, 2020, Nontarget screening of per-and polyfluoroalkyl substances binding to human liver fatty acid binding protein, Environ. Sci. Tech., 54, 5676, 10.1021/acs.est.0c00049 · DOI · Paper page
  102. Yao, 2023, Emerging and Legacy Perfluoroalkyl Substances in Breastfed Chinese Infants: Renal Clearance, Body Burden, and Implications, Environ. Health Perspect., 131, 37003, 10.1289/EHP11403 · DOI
  103. Yee, 2021, Emerging Roles of the Human Solute Carrier 22 Family, Drug Metab. Dispos., 50, 1193, 10.1124/dmd.121.000702 · DOI · Paper page
  104. Yi, 2019, Probing the hepatotoxicity mechanisms of novel chlorinated polyfluoroalkyl sulfonates to zebrafish larvae: Implication of structural specificity, Environ. Int., 133, 10.1016/j.envint.2019.105262 · DOI
  105. Young, 2021, Assessing Indoor Dust Interference with Human Nuclear Hormone Receptors in Cell-Based Luciferase Reporter Assays, Environ. Health Perspect., 129, 47010, 10.1289/EHP8054 · DOI
  106. Zhang, 2021, Varied thyroid disrupting effects of perfluorooctanoic acid (PFOA) and its novel alternatives hexafluoropropylene-oxide-dimer-acid (GenX) and ammonium 4,8-dioxa-3H-perfluorononanoate (ADONA) in vitro, Environ. Int., 156, 10.1016/j.envint.2021.106745 · DOI · Paper page
  107. Zhao, 2014, Concentration-dependent polyparameter linear free energy relationships to predict organic compound sorption on carbon nanotubes, Sci. Rep., 4, 3888, 10.1038/srep03888 · doi:10.1038/srep03888
  108. Zoete, 2007, Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of, Lipids, 1771, 915

Cited by

See all 218

Metadata

Authors
Zhao, L., Teng, M., Zhao, X., Li, Y., Sun, J., Zhao, W., Ruan, Y., Leung, K. M. Y., & Wu, F.
Venue
Environment International
Publisher
Elsevier BV
Published
2023-05
Volume
175
Pages
107951
ISSN
0160-4120 (ISSN-L)
OpenAlex
W4367322125
Cited by
218
References
36
FWCI
17.88
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • State Key Laboratory in Marine Pollution
  • National Natural Science Foundation of China (42207335)
  • Ministry of Science and Technology of the People's Republic of China
  • Innovation and Technology Commission (PJ9448002)
  • China Academy of Space Technology
  • China Association for Science and Technology (2022QNRC001)
  • National Key Research and Development Program of China (2021YFC3201000)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.